THE MANAGEMENT OF CANCER PAIN

被引:63
作者
CHERNY, NI
PORTENOY, RK
机构
[1] Memorial Sloan‐Kettering Cancer Center, New York, New York
[2] Analgesic Studies in the Pain Service, Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York
[3] Department of Internal Medicine, Shaare Zedek Medical Center, Jerusalem
关键词
D O I
10.3322/canjclin.44.5.263
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Surveys indicate that clinicians are frequently ill equipped to treat cancer pain. Pain is often poorly assessed, and many caregivers lack sufficient knowledge to optimize treatment. Effective management requires an understanding of pain pathophysiology, the ability to identify and evaluate pain syndromes, and familiarity with proven therapeutic strategies. Opioid pharmacotherapy is the mainstay of treatment. Practical aspects of opioid therapy include selection of both drug and route, dose titration, and management of side effects. Specific strategies for the management of patients who are unable to attain an acceptable balance between pain relief and side effects include both noninvasive interventions (such as adjuvant analgesics, psychological therapies, and physiatric techniques) and invasive interventions (such as the use of intraspinal opioids, neural blockade, and neuroablative therapies). Sedation is an option at the end of life for the treatment of pain that is refractory to other interventions. These approaches can provide adequate relief to the vast majority of patients, most of whom will respond to systemic pharmacotherapy alone. Patients with refractory pain should have access to specialists in pain management or palliative medicine.
引用
收藏
页码:262 / 303
页数:42
相关论文
共 209 条
  • [1] Johanson GA, Symptom character and prevalence during cancer patients' last days of life, Am J Hosp Palliat Care, 8, 2, pp. 6-8, (1991)
  • [2] Bonica JJ, Ventafridda V, Twycross RG, Cancer pain, The Management of Pain, pp. 400-460, (1990)
  • [3] Coyle N, Adelhardt J, Foley KM, Portenoy RK, Character of terminal illness in the advanced cancer patient: Pain and other symptoms during last four weeks of life, Journal of Pain and Symptom Management, 5, pp. 83-93, (1990)
  • [4] Portenoy RK, Miransky J, Thaler HT, Et al., Pain in ambulatory patients with lung or colon cancer: Prevalence, characteristics, and effect, Cancer, 70, pp. 1616-1624, (1992)
  • [5] Twycross RG, Fairfield S, Pain in far‐advanced cancer, Pain, 14, pp. 303-310, (1982)
  • [6] Brescia FJ, Adler D, Gray G, Et al., Hospitalized advanced cancer patients: a profile, Journal of Pain and Symptom Management, 5, pp. 221-227, (1990)
  • [7] Ventafridda V, Ripamonti C, De Conno F, Et al., Symptom prevalence and control during cancer patients' last days of life, J Palliat Care, 6, pp. 7-11, (1990)
  • [8] Massie MJ, Holland JC, The cancer patient with pain: Psychiatric complications and their management, Med Clin North Am, 71, pp. 243-258, (1987)
  • [9] Cleeland CS, The impact of pain on the patient with cancer, Cancer, 54, pp. 2635-2641, (1984)
  • [10] Ventafridda V, De Conno F, Ripamonti C, Et al., Quality‐of‐life assessment during a palliative care programme, Ann Oncol, 1, pp. 415-420, (1990)